Antiviral therapy, HBsAg seroclearance and late recurrence of hepatitis B-related hepatocellular carcinoma.

J Hepatol

Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Cancer Center, Affiliated People's Hospital of Hangzhou Medical College, Zhejiang Provincial People's Hospital, Zhejiang, China; The Key Laboratory of Imaging Diagnosis and Minimally Invasive Interventional Research of Zhejiang Province, Zhejiang University Lishui Hospital, Zhejiang, China. Electronic address:

Published: November 2022

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jhep.2022.07.005	DOI Listing

Publication Analysis

Top Keywords

antiviral therapy

therapy hbsag

hbsag seroclearance

seroclearance late

late recurrence

recurrence hepatitis

hepatitis b-related

b-related hepatocellular

hepatocellular carcinoma

antiviral

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!